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newer, more effective treatments which minimize exacer-
bations leading to hospitalizations.
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PROBLEMATIC ISSUES OF THE QUALITY OF 
ASTHMA MANAGEMENT IN RURAL AREAS
IN GREECE
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1Health Economics, AstraZeneca S.A., Athens, Greece; 2School 
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OBJECTIVES: In the Greek National Health System Pri-
mary health care centres (PHCs) staffed with qualified
General Practitioners (GPs) and non-specialized medical
graduates (rural doctors), obliged to serve in those areas
for nine months, provide care to rural populations. How-
ever, quality of patient care has not been adequately as-
sessed. Combining data from a study aiming to assess the
impact of providers’ education on asthma management,
and qualitative observational assessments from the pa-
tient and provider population, we aim to identify quality
issues of asthma management in the rural population of
Greece. METHODS: Eight PHCs were randomly chosen
in Crete Island and 30 doctors were randomly assigned
to intervention (21) and control groups (9). Interventions
included: intensive educational course from local Univer-
sity Respiratory Clinic, distribution of the GINA asthma
guidelines, specific patient follow-up forms. The inter-
vention doctors identified 102 patients with a verified
asthma diagnosis by a specialist. Follow-up visits were
scheduled at 0, 16 and 32 weeks. Assessments included
trigger factors prevalence, symptom based scores, PEF
and FEV1, and QoL (AQLQ). Patient dropout and pro-
viders’ adherence to the study schedule were investigated.
RESULTS: Initial qualified GPs’ knowledge on asthma
management was poor before but improved after the ed-
ucational course. The intervention doctors showed vari-
able adherence to the study schedule. Reasons include the
termination of rural center residence for rural doctors, in-
creased workload and organizational factors for qualified
GPs. Reasons for patients’ non-adherence include termi-
nation of rural doctors’ term, distance from PHC, profes-
sional reasons etc. Poor professional and patient adher-
ence resulted in an increased prevalence of trigger factors,
including smoking, house dust, in house dampness (smell),
and fireplace smoke. CONCLUSIONS: The quality of
asthma management in rural areas seems poor. Guideline
knowledge does not ensure adherence. Organizational,
behavioural and cultural factors should be further studied.
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AGE AND GENDER DIFFERENCES IN 
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To examine the age and gender differences in children
and young adults aged 0–25 in the utilization of asthma
medications. METHODS: The Medicines Monitoring Unit
(MEMO) captures all dispensed medication for the Tay-
side area (population 400,000) and carries out demo-
graphic and drug safety studies. This study examined the
dispensing of asthma medications for 1993 to 1995. RE-
SULTS: From the MEMO databases 130,372 subjects
aged 25 or under were identified. Of this group 18.1% of
males and 16.3% of females had received at least one
prescription for asthma medication. Stratifying by age in
four year bands the age group 1–4 years had the highest
proportion of children with an asthma prescription (29.4%
of males and 23.5% of females, P  0.001 chi squared
test). The proportion of males with an asthma prescrip-
tion was consistently higher than females until the age of
19 after which there was a higher proportion of females.
Logistic regression analysis showed that males were more
likely to be dispensed a prescription for asthma medica-
tion than females (odds ratio 1.14, 95% CI 1.11–1.18, P 
0.001). Those aged under 20 were twice as likely to have
a prescription as those aged 20–25 (odds ratio 2.02, 95%
CI 1.95–2.10, P  0.001). After adjusting for age, gender
and an age and gender interaction, males were still more
likely to have a prescription for asthma than females
(odds ratio 1.72, 95% CI 1.59–1.85, P  0.001). DIS-
CUSSION: The results for males may reflect a higher in-
cidence of asthma or a prescribing bias. The higher num-
ber of females prescribed asthma medications after age
19 may reflect better compliance or a greater number of
GP consultations.
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OBJECTIVES: To investigate the change in quality of life
and wellbeing in children with bronchial asthma (BA).
METHODS: For estimation of quality of life we used
“Childhood questionnaires” (1991–1995) by A. West, D.
French, adapted for Russian by V. Petrov and I. Smole-
nov (1996–1998). In child’s municipal asthma-centre
questionnaire was conducted in 264 children with BA
and 55 children without this disease, age from 4 to 16.
RESULTS of questionnaire showed considerable decreas-
ing quality of daily life in children (4–7 years old) mainly
in severe and middle severe asthma (30,1 against 36,1
marks in healthy patient (P  0,01) and 36,75 in patients
with mild asthma). Increasing of distress degree was de-
fined in all age groups. In children 4–7 years old with
mild asthma the distress mark was 11,75; in middle se-
vere, 12,5; in children 8–11 years old, 21,4 and 24,89
marks high distress mark. Analogous increasing distress
marks with worsening asthma was revealed in children
12–16 years old (38,5 marks in mild BA; 45,07 in middle
severe; 49,5 in severe BA). Quality of daily life in children
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4-7 years old and active life in children 8–11 years old in
mild BA did not differ comparing with healthy children
(36,75 against 35,9 marks and 30,16 against 29,71 marks
conformably) but decreased with worsening disease (30,1
and 26,77 in middle severe and severe BA). Mild and
middle severe BA impacted on quality of child’s life a lit-
tle but severe BA restricted child’s life considerably
(19,23–20,25 and 16,2 marks conformably). CONCLU-
SION: Analysis revealed considerable decreasing quality
of life in children with BA, restriction in physical, psych-
oemotional and social spheres of life. Questionnaire
adapted by V. Petrov and I. Smolenov was exact; that is
why this wellbeing questionnaire was able to use such
criterion of treatment effectiveness in children with BA.
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OBJECTIVE: To examine the health resource use by pa-
tients with chronic obstructive airway disease (COAD)
from the perspective of a public health organization.
METHODS: Seventy-one patients with exacerbation of
COAD admitted to the medical wards of a public hospi-
tal in Hong Kong during a six-week period were studied.
They were interviewed using a structured questionnaire
and their medical history was reviewed. During the inter-
view, patients’ background, level of disease knowledge
and their drug treatment were obtained. Direct medical
costs during hospitalization were estimated from their
hospital records. The annual direct medical costs due to
COAD were estimated from the number of COAD hospi-
tal admissions and the median cost of hospitalization of
our study patients. RESULTS: 72% percent of patients
attended regular follow-up visits for COAD but none at-
tended the rehabilitation program offered on an outpa-
tient basis. 85% of patients had used bronchodilator in-
halation therapy on a regular basis. The disease knowledge
of the study patients was generally poor. For the current
exacerbation, 42% of patients had visited private medi-
cal practitioners prior to admission. The median duration
of hospital stay was 5 days (range 3–33 days). There
were a total of 42,241 admissions per year due to COAD
in the whole territory. Average cost of hospitalization
was HK$3,632/day (1US$  7.8HK$). The annual hos-
pital cost for patients with COAD exacerbation was esti-
mated to be about HK$767 million, representing about
2.4% of the annual total health care budget in Hong
Kong. CONCLUSION: The cost of hospitalization of pa-
tients with COAD exacerbation was high. Patient knowl-
edge could be improved and outpatient rehabilitation
program could be further publicized.
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OBJECTIVE: To characterize the treatment and costs
associated to rhinitis in a managed care population.
METHODS: All subjects contained within PharMetric’s
Integrated Outcomes database possessing a diagnosis of
rhinitis (ICD-9-CM  477) and a prescription claim for a
rhinitis specific medication during 1997–1998 were eligi-
ble for study inclusion. Patients were required to have 12
months of data following the first (index) rhinitis diagno-
sis present. Patients were stratified according to the num-
ber of comorbid conditions (0 comorbidities, 1 comor-
bidity, 	 1 comorbidity). Measured conditions included
upper respiratory infections, sinusitis, asthma, bronchitis,
conjunctivitis, and otitis media. Patient demographics,
rhinitis specific charges, and comorbid conditions were
captured for each patient during the study period. RE-
SULTS: 202,426 patients met the inclusion criteria. The
mean age was 33.9 years (SD  17.7) and 61.4% were
female. The most commonly identified comorbid condi-
tions were upper respiratory infection (32.2%) and si-
nusitis (34.2%). The proportion of females increased
with the presence of comorbid conditions, as did pre-
scription therapy. The most common antihistamine was
loratadine, which was prescribed to approximately 57%
followed by fexofenadine (19%) and cetirizine (14%).
Nasal steroids were prescribed to over half of the sample
(58%). Mean rhinitis specific treatment charges for the
12 months following initial diagnosis range from $371
(SD  365) to $590 (SD  642) for patients with 2 or
more comorbidities. CONCLUSION: Rhinitis is a preva-
lent condition within this managed care population, asso-
ciated with substantial utilization of healthcare resources.
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Bronchial asthma is a chronic disease, having an increas-
ing prevalence and causes an increasing burden to the
health care. Understanding the drug costs and use of the
drug will help to rationalise the drug use. OBJECTIVES:
1) give a picture of asthma in Hungary concerning the ep-
idemiological data; 2) analyze the anti-asthma drug use
and costs in Hungary; 3) define the changes in the drug
use in hospitals which are specialised for asthma; 4) ana-
lyze the connection between the drug consumption data
and the epidemiological data. METHODS: The epidemi-
ological data was given by the Hungarian Pulmonologist
Association. Between 1989 and 1998 the drug consump-
